Aurora Cannabis

ACB

Market cap $295M

The Canadian cannabis market continues to play a crucial role in the global marijuana industry. As U.S. legalization efforts gain traction, Canadian producers are positioning themselves for renewed growth and cross-border opportunities. The U.S. cannabis industry is projected to exceed $56 billion by 2030, supported by expanding state programs and rising consumer acceptance. Recently, discussions surrounding federal reclassification and potential legalization have fueled optimism across both Canadian and American markets. Consequently, many investors are closely watching leading Canadian stocks for potential breakouts. However, it is vital to remember that momentum can shift quickly in this volatile sector. Therefore, traders should focus on quality setups and confirm strength using technical analysis tools such as trendlines, volume indicators, and moving averages.

Aurora Cannabis (ACB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

In case you haven't heard, President Donald Trump just gave his "strongest signal yet that movement on cannabis policy may be imminent" and that the federal government may be ready to finally legalize marijuana use in the U.S.

Cannabis stocks are in focus after President Trump said CBD could "revolutionize senior healthcare" in a Truth Social post. The comment sent bullish signals through the cannabis space, coming months after reports that the president was considering reclassifying weed.

Marijuana stocks are getting some attention this week following new interest from President Donald Trump.

Cannabis stocks surged after Trump endorsed CBD for senior healthcare, citing its potential to revolutionize treatment and reduce healthcare costs. Shares of TLRY, CGC, CRON, and ACB soared double digits, with related ETFs MSOS and MJ also posting significant gains.

Cannabis stocks lit up Wall Street after Donald Trump backed a push to bring CBD under Medicare. The former president reposted a three-minute video from The Commonwealth Project, a campaign arguing that older Americans should have access to hemp-derived cannabidiol.

Cannabis stocks got a pop on Monday after President Trump shared a video highlighting potential health benefits of CBD, reigniting speculation that his administration could reclassify the drug, CNBC's Brandon Gomez reports.

Aurora Cannabis Inc (NASDAQ: ACB) rallied more than 25% this morning after President Trump endorsed cannabidiol (CBD) as potential breakthrough in senior healthcare. In a social media post over the weekend, the US President said CBD could “revolutionise senior healthcare” and hinted at reclassifying marijuana at the federal level.

Tilray Brands surged nearly 20% and was up 36% after market open, while Canopy Growth jumped about 20% and Cronos Group rose 13%.